Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generic prescribing for epilepsy. Is it safe?

P Crawford1, W W Hall, B Chappell

  • 1Department of Neurology, Bootham Park Hospital, York, UK.

Seizure
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of serial in vitro haemodilution with maternal cerebrospinal fluid and crystalloid on thromboelastographic (TEG(®) ) blood coagulation parameters, and the implications for epidural blood patching.

Anaesthesia·2014
Same author

The reliability of the modified lower extremity functional scale among adults living with HIV on antiretroviral therapy, in Rwanda, Africa.

SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance·2014
Same author

Endoscopy supply water and final rinse testing: five years of experience.

The Journal of hospital infection·2014
Same author

AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines.

Lung cancer (Amsterdam, Netherlands)·2014
Same author

Health risk estimates for groundwater and soil contamination in the Slovak Republic: a convenient tool for identification and mapping of risk areas.

Environmental geochemistry and health·2014
Same author

HOW TO…: Use Videodiscs in Medical Education, Part 1.

Medical teacher·2014
Same journal

Development of a standard for epilepsy semiology and semiological description dataset: a modified Delphi study.

Seizure·2026
Same journal

UNC13A-related neurodevelopmental disorders in children: epilepsy phenotypes and antiseizure medication response.

Seizure·2026
Same journal

Switching from oxcarbazepine to eslicarbazepine in patients with focal epilepsy: A systematic review and single-arm meta-analysis.

Seizure·2026
Same journal

Efficacy, tolerability, and EEG lateralization-based predictors of neuropsychiatric adverse events in pediatric SeLECTS treated with perampanel monotherapy.

Seizure·2026
Same journal

Cross-cultural validation of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) in Chinese-speaking people with epilepsy.

Seizure·2026
Same journal

Unlocking seizure freedom: A European Delphi panel study on the clinical, humanistic, and economic value of seizure control in epilepsy.

Seizure·2026
See all related articles

Switching generic antiepileptic drugs may cause seizures or side effects. This study found potential negative health impacts outweighing cost savings, impacting epilepsy patient care and increasing healthcare burdens.

Area of Science:

  • Pharmacology and Neurology
  • Public Health and Healthcare Management

Background:

  • Generic prescribing of antiepileptic drugs (AEDs) for epilepsy is debated.
  • Concerns exist regarding potential adverse events and therapeutic efficacy when switching between AED manufacturers.

Purpose of the Study:

  • To investigate if switching generic manufacturers of AEDs leads to changes in seizure incidence or side effects.
  • To evaluate the impact of generic AED switching on patient health and healthcare resource utilization.

Main Methods:

  • A study involving 40 general practices and 2285 epilepsy patients using carbamazepine, phenytoin, or sodium valproate.
  • Questionnaires were distributed to patients, followed by interviews for those reporting issues after switching AED manufacturers.

Main Results:

Related Experiment Videos

  • Out of 1333 respondents, 251 (18.7%) reported switching AED manufacturers.
  • 10.8% of switchers had validated problems, while 9.9% had unproven issues; 70.5% reported no problems.

Conclusions:

  • The cost savings from generic prescribing may be offset by negative health outcomes for epilepsy patients.
  • Increased patient problems and workload for general practices suggest potential negative impacts on healthcare efficiency and social costs.